Cargando…
Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov. We conducted a cross-sectional analysis of phase III trials with primary results published...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376878/ https://www.ncbi.nlm.nih.gov/pubmed/32703252 http://dx.doi.org/10.1186/s13063-020-04603-9 |